News


12-08-2017 New products from MATRIKS BIOTEK! New SHIKARI® ELISA kits for Total Antibody detection to Infliximab (Remicade®), Infliximab-biosimilar (Remsima®) and Adalimumab (Humira®)


11-28-2017 New article. SHIKARI® Q-CETUX ELISA kit have been used to measure cetuximab levels in a comparative study with a new method utilizing LC-MS/MS method and validated accordingly


11-24-2017 New SHIKARI® ELISA kits for total anti-drug antibodies to Infliximab, Infliximab-biosimilar, CT-P13 and Adalimumab will be launched very soon! click to see details


11-21-2017 New publication Johannes Gojo, Robert Sauermann, Ursula Knaack, Irene Slave, Andreas Peyrl, Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies. Drugs R D 17:469-474, 2017


09-09-2017 Our new Distributiors; IWAI JAPAN and USA, BioChemMack JCS Russia..


07-27-2017 5 New Publications are added; 2 patents, 2 peer reviewed articles and 1 PhD thesis..


07-10-2017 five new products for Pembrolizumab(Keytruda®),Ipilimumab(Yervoy®) and Filgrastim.


02-20-2017 new publication “H. Akbulut, et al: The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). 1553 P, Annals of Oncology, Volume 27, 2016.


02-20-2017 New kit for quantitative measurement of anti-bevacizumab antibodies with confirmation reagentdone by using SHIKARI® ELISA kits.


02-06-2017 Two new kits for quantitative measurement of rituximab and anti-rituximab antibodies with confirmation reagent.


01-30-2017 Three new kits for quantitative measurement of anti-drug antibodies for infliximab, infliximab biosimilar CT-P13 and adalimumab with confirmation reagent.


01-13-2017 Updated forty publications done by using SHIKARI® ELISA kits.


MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Intl.calls&Whatsapp: +90 (546) 485 42 94
Email: info@matriksbiotek.com
Email: order@matriksbiotek.com
Fax: +90 (312) 485 11 87